Anika Therapeutics, Inc.

NASDAQ:ANIK

16.33 (USD) • At close December 24, 2024
Bedrijfsnaam Anika Therapeutics, Inc.
Symbool ANIK
Munteenheid USD
Prijs 16.33
Beurswaarde 239,162,648
Dividendpercentage 0%
52-weken bereik 15.83 - 29.12
Industrie Medical Devices
Sector Healthcare
CEO Dr. Cheryl Renee Blanchard Ph.D.
Website https://www.anikatherapeutics.com

An error occurred while fetching data.

Over Anika Therapeutics, Inc.

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on

Vergelijkbare Aandelen

InterCure Ltd. logo

InterCure Ltd.

INCR

1.06 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

7.33 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

3.69 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

3.87 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

1.83 USD

Absci Corporation logo

Absci Corporation

ABSI

3.01 USD

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.87 USD

Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc.

CMPX

1.5 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

1.58 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)